Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 519c (miR-519c) is a primate-specific, small non-coding RNA processed from the C19MC cluster located on chromosome 19q13.41-42. It serves as a post-transcriptional regulator by binding to specific regions of target mRNAs, repressing their translation or facilitating degradation. miR-519c is implicated in controlling cell proliferation, cell cycle, and apoptosis primarily by targeting mRNAs such as HuR (ELAVL1) and HIF-1α, thereby affecting cancer cell growth and response to microenvironmental stress. miR-519c is downregulated in several cancers, such as breast and pancreatic cancer, and has been explored as a tumor suppressor, a biomarker, and an element of experimental combination therapeutics to overcome drug resistance[1][2][3][5].
miR-519c downregulates target mRNAs by binding their coding or untranslated regions, repressing translation or leading to degradation; known targets include HIF-1α mRNA and HuR (ELAVL1) mRNA, leading to reduction in protein levels and modulation of downstream pathways[1][3][5]
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 519c (miR-519c).